Meg Doherty

11.6k total citations · 3 hit papers
121 papers, 6.8k citations indexed

About

Meg Doherty is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Meg Doherty has authored 121 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Infectious Diseases, 54 papers in Epidemiology and 41 papers in Virology. Recurrent topics in Meg Doherty's work include HIV/AIDS Research and Interventions (96 papers), HIV/AIDS drug development and treatment (42 papers) and HIV Research and Treatment (40 papers). Meg Doherty is often cited by papers focused on HIV/AIDS Research and Interventions (96 papers), HIV/AIDS drug development and treatment (42 papers) and HIV Research and Treatment (40 papers). Meg Doherty collaborates with scholars based in Switzerland, United States and United Kingdom. Meg Doherty's co-authors include David Vlahov, Marco Vitória, Nathan Ford, Kenrad E. Nelson, Richard S. Garfein, Noya Galai, Edward J. Mills, Richard S. Garfein, Zara Shubber and Sabin Nsanzimana and has published in prestigious journals such as JAMA, Nature Communications and PLoS ONE.

In The Last Decade

Meg Doherty

113 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

1996 581 citations David Vlahov, Meg Doherty et al. profile →
Severe Community-Onset Pneumonia in Healthy Adults Caused by Methicillin-Resistant Staphylococcus aureus Carrying the Panton-Valentine Leukocidin Genes

2004 560 citations Meg Doherty et al. Clinical Infectious Diseases profile →
Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis

2016 353 citations Zara Shubber, Edward J. Mills et al. PLoS Medicine profile →

Peers

Countries citing papers authored by Meg Doherty

Since Specialization

Citations

This map shows the geographic impact of Meg Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meg Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meg Doherty more than expected).

Fields of papers citing papers by Meg Doherty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meg Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meg Doherty. The network helps show where Meg Doherty may publish in the future.

Co-authorship network of co-authors of Meg Doherty

This figure shows the co-authorship network connecting the top 25 collaborators of Meg Doherty. A scholar is included among the top collaborators of Meg Doherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meg Doherty. Meg Doherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reducing HIV incidence and mortality: two sides of the same coin in the approach to ending AIDS 2025 ·The Lancet HIV ·Joseph N Jarvis, Peter Ehrenkranz, David S. Lawrence, Claire Keene, Michael Reid, Ingrid T. Katz, (unknown), Carmen Pérez Casas, (unknown), (unknown), Aleny Couto, Meg Doherty, Ajay Rangaraj, Nathan Ford	0
2	Comparative analyses of COVID-19 in-hospital mortality in people with HIV during SARS-CoV-2 pre-Delta, Delta, and Omicron waves 2025 ·AIDS ·Seth Inzaule, Ronaldo Silva, Nathan Ford, Soe Soe Thwin, (unknown), Alimuddin Zumla, Meg Doherty, Janet Dı́az, Silvia Bertagnolio	1
3	Prevalence of advanced HIV disease in sub-Saharan Africa: a multi-country analysis of nationally representative household surveys 2025 ·The Lancet Global Health ·Dominik Stelzle, Ajay Rangaraj, Joseph N Jarvis, (unknown), (unknown), Daniel Low‐Beer, Meg Doherty, Nathan Ford, Shona Dalal	7
4	Role of viral suppression in HIV treatment and prevention and its potential in addressing harmful laws and discrimination 2023 ·Sexual Health ·(unknown), Rachel Baggaley, Lara Vojnov, Meg Doherty	1
5	Prevalence of undiagnosed HIV among children in South Africa, Côte d'Ivoire and Zimbabwe: a model‐based analysis to inform paediatric HIV screening programmes 2022 ·Journal of the International AIDS Society ·(unknown), (unknown), Martina Penazzato, Clare Flanagan, Elaine J. Abrams, Caitlin M. Dugdale, Leigh F. Johnson, Anne M. Neilan, Mary‐Ann Davies, Kenneth A. Freedberg, Patricia Fassinou, Meg Doherty, Shaffiq Essajee, Angela Mushavi, Djøra I. Soeteman, Andrea Ciaranello	5
6	Surveillance of ARV safety in pregnancy and breastfeeding: towards a new framework 2022 ·Journal of the International AIDS Society ·Françoise Renaud, Lynne Mofenson, (unknown), Helen Dolk, Valériane Leroy, (unknown), Leyla Şahin, Roger Shapiro, Amy L. Slogrove, Claire Thorne, (unknown), Daniel Low‐Beer, Meg Doherty	10
7	The performance of using dried blood spot specimens for HIV-1 viral load testing: A systematic review and meta-analysis 2022 ·PLoS Medicine ·Lara Vojnov, Sergio Carmona, Clement Zeh, Jessica Markby, Debrah I. Boeras, Marta R. Prescott, (unknown), Souleymane Sawadogo, Christiane Adjé-Touré, Guoqing Zhang, (unknown), Wendy Stevens, Meg Doherty, Chunfu Yang, Heather Alexander, Trevor Peter, John N. Nkengasong	21
8	Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects 2019 ·Journal of the International AIDS Society ·Lynne Mofenson, Anton Pozniak, (unknown), Elliot Raizes, Andrea Ciaranello, Polly Clayden, Peter Ehrenkranz, Ade Fakoya, Andrew Hill, Saye Khoo, Imelda Mahaka, Surbhi Modi, Cynthia A. Moore, Andrew Phillips, George K. Siberry, (unknown), Claire Thorne, Heather Watts, Meg Doherty, Nathan Ford	30
9	The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries 2018 ·AIDS ·Marco Vitória, Andrew Hill, Nathan Ford, Meg Doherty, Polly Clayden, François Venter, David H. Brown Ripin, Charles Flexner, Paul L. Domanico	76
10	Clinical and public health implications of acute and early HIV detection and treatment: a scoping review 2017 ·Journal of the International AIDS Society ·Sarah E. Rutstein, Jintanat Ananworanich, Sarah Fidler, Cheryl Johnson, Eduard J. Sanders, Omar Sued, Asier Sáez‐Cirión, Christopher D. Pilcher, Christophe Fraser, Myron S. Cohen, Marco Vitória, Meg Doherty, Joseph D. Tucker	100
11	Enhancing Public Health HIV Interventions: A Qualitative Meta-Synthesis and Systematic Review of Studies to Improve Linkage to Care, Adherence, and Retention 2017 ·EBioMedicine ·Joseph D. Tucker, Lai Sze Tso, Brian J. Hall, Qingyan Ma, Rachel Beanland, John Best, Haochu Li, Mellanye Lackey, Gifty Marley, Zachary C. Rich, (unknown), Meg Doherty	38
12	Stable patients and patients with advanced disease: consensus definitions to support sustained scale up of antiretroviral therapy 2016 ·Tropical Medicine & International Health ·Greer Waldrop, Meg Doherty, Marco Vitória, Nathan Ford	47
13	Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis breakdown → 2016 ·PLoS Medicine ·Zara Shubber, Edward J. Mills, Jean B. Nachega, Rachel Vreeman, Marcelo Araújo de Freitas, Peter Bock, Sabin Nsanzimana, Martina Penazzato, (unknown), Meg Doherty, Nathan Ford	353
14	Definitions of implementation science in HIV/AIDS 2015 ·The Lancet HIV ·Thomas Odeny, Nancy Padian, Meg Doherty, Stefan Baral, Chris Beyrer, Nathan Ford, Elvin Geng	43
15	The Strategic Use of Antiretrovirals to Prevent HIV Infection: A Converging Agenda 2015 ·Clinical Infectious Diseases ·Rachel Baggaley, Meg Doherty, Andrew Ball, Nathan Ford, Gottfried Hirnschall	19
16	Adherence to HIV postexposure prophylaxis 2014 ·AIDS ·Nathan Ford, Cadi Irvine, Zara Shubber, Rachel Baggaley, Rachel Beanland, Marco Vitória, Meg Doherty, Edward J. Mills, Alexandra Calmy	64
17	Strategies to Reduce Unplanned Hospitalizations of Home Healthcare Patients 2006 ·Home Healthcare Nurse ·(unknown), (unknown), Meg Doherty	14
18	HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old 1999 ·Drug and Alcohol Dependence ·Mariângela Carneiro, Crystal M. Fuller, Meg Doherty, David Vlahov	50
19	Gender Differences in Injection-Related Behaviors Among Injection Drug Users in Baltimore, Maryland 1998 ·AIDS Education and Prevention ·Carl A. Latkin, Wallace Mandell, Amy R. Knowlton, Meg Doherty, David Vlahov, Tae Suk Suh, David D. Celentano	55
20	Prevalence and Incidence of Hepatitis C Virus Infection Among Young Adult Injection Drug Users 1998 ·Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Richard S. Garfein, Meg Doherty, Edgar R. Monterroso, David L. Thomas, Kenrad E. Nelson, David Vlahov	298

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact